Aranya Jeeraka: Benefits, Evidence & Safety

TL;DR

Aranya jeeraka is bitter cumin seed (Centratherum anthelminticum), traditionally used to expel intestinal worms. Two small non-blinded randomized trials in Karachi type-2 diabetes patients found 500 mg of seed powder daily for 12 weeks, added to metformin, lowered HbA1c and fasting glucose. Early evidence, never tested as a metformin replacement.

What it is

Aranya jeeraka (also spelled aranya jiraka; Sanskrit synonyms include Vanajiraka, Kaalijiri, and Somaraji, not to be confused with Bakuchi) is the dried seed of Centratherum anthelminticum (Kuntze), synonym Vernonia anthelmintica, in the Asteraceae family: a 40–60 cm annual herb with purple flowers found across India in waste lands (Easy Ayurveda; SSM Ayurvedic College monograph). Its English names include purple fleabane and bitter cumin; in Hindi it is kali jeeri.

Now the warning, because this one has bitten real buyers. Some online sellers label ordinary cumin (Cuminum cyminum) as "aranya jeeraka." That is a trade mislabeling, not the Ayurvedic drug. If the Latin name on the packet isn't Centratherum anthelminticum, you are holding the wrong plant.

Traditional use

Aranya jeeraka is classified in the Pippalyadi varga of the Raja Nighantu (Easy Ayurveda). Classical indications center on intestinal worms (krimi), its signature traditional use, along with skin diseases (kustha, kandu), cough and asthma (kasa, swasa), fever, colic (gulma), wounds, and general debility, with gynecological disorders also mentioned in Ayurvedic practice (Easy Ayurveda; SSM Ayurvedic College monograph). Its Ayurvedic pharmacology is described as pungent and bitter in taste (katu, tikta rasa), hot in potency (ushna virya), and kapha-vata pacifying.

These are traditional claims, not clinical proof. And there is an irony on this page that I won't let slide: the signature traditional use, worms, is the one with no human trials at all. The human research is on diabetes. Separate questions, separate verdicts, below.

What modern research says

Blood sugar and lipids in type-2 diabetes (two randomized trials)

Two non-blinded randomized controlled trials from the same Karachi research group tested 500 mg capsules of C. anthelminticum seed powder daily for 12 weeks in type-2 diabetes patients. Same group, same city, small numbers: read these as one thread of early evidence, not two independent confirmations.

Trial 1 (n=40 patients + 20 healthy volunteers). A non-blind randomized controlled trial (October–December 2019) compared metformin 500 mg alone (n=20) against metformin 500 mg plus a 500 mg seed-powder capsule (n=20), with a third group of 20 healthy volunteers taking the seed capsule. After 6 and 12 weeks, the add-on group showed significant reductions in HbA1c and fasting blood glucose (p<0.0001), body weight, coronary risk index, atherogenic index (p<0.0001), atherogenic dyslipidemia ratio, total cholesterol and triglycerides, with HDL increased and LDL decreased at 12 weeks (randomized trial, PMID 39867806).

Trial 2 (n=60). A randomized, non-blinded, controlled 3-month trial gave diabetic patients either metformin 500 mg (n=20) or metformin plus a 500 mg seed-powder capsule daily (n=20), plus healthy volunteers (n=20) taking the capsule. The seed powder significantly reduced percentage glycaemia (p<0.0001) and Hb glycosylation (p<0.05), along with serum risk markers: direct bilirubin and uric acid (p<0.01), creatine kinase and ALT (p<0.0001), and creatinine (p<0.05), suggesting a synergistic effect with metformin (randomized trial, PMID 38264892).

Both trials are small, non-blinded, single-center, and short. Early evidence, not proof. And the sentence I will repeat until it sticks: both tested the seed powder only as an add-on to metformin, never as a replacement for it.

Laboratory research (not human evidence)

Two laboratory studies exist, and I park them here so nobody confuses them with the trials above. A 2024 laboratory study investigated the anti-filarial activity of C. anthelminticum using biochemical and high-resolution proteomic methods, an in-vitro and mechanistic study (PMID 39139251). It does not establish a worm treatment in people. A 2024 study synthesized silver nanoparticles using C. anthelminticum extract and tested them against breast cancer cells in the laboratory (PMID 39205569). Materials research, not cancer-treatment evidence. Test tubes are not patients.

What the evidence does not support (yet)

The signature traditional use, expelling intestinal worms, has not been tested in any published human trial. The species name promises anthelminticum. The data don't. Nothing in the human data supports using aranya jeeraka as a substitute for prescribed diabetes medication either.

Dosage

The only human regimens with a citable source are the two trial doses: **500 mg of C. anthelminticum seed powder in capsule form, once daily for 12 weeks**, studied as an add-on to metformin 500 mg in type-2 diabetes patients (PMID 39867806; PMID 38264892). This is a research regimen, not a personal recommendation, and no pharmacopoeial (API/AFI) dose for aranya jeeraka was identified. Do not self-dose. Consult a qualified practitioner.

Safety & contraindications

Human safety data are limited to the two small 12-week trials above, which were not designed as safety studies and reported no safety analysis beyond the measured markers (PMID 39867806; PMID 38264892). There are no published data on use in pregnancy, breastfeeding, or children: avoid in these groups without clinical guidance. Because both trials studied the seed powder only alongside metformin, do not combine it with diabetes medication or adjust prescribed doses on your own.

The seeds are intensely bitter with a strong odor. Buy only products that state the Latin name Centratherum anthelminticum, since trade mislabeling with ordinary cumin is common. Safety data is limited: talk to a clinician.

FAQs

What is aranya jeeraka — is it the same as cumin?

No. Aranya jeeraka is the seed of Centratherum anthelminticum (bitter cumin, kali jeeri), a member of the daisy family used in Ayurveda mainly for intestinal worms (Easy Ayurveda). Ordinary cumin is Cuminum cyminum, a different plant. Some sellers mislabel cumin as "aranya jeeraka," so check the Latin name on any product. Really check it. This is the one practical takeaway I want every buyer to leave with.

Does aranya jeeraka help with diabetes?

Two small non-blinded randomized trials (n=40 and n=60, 12 weeks) found that 500 mg of seed powder daily, added to metformin, lowered HbA1c, fasting glucose and several lipid and risk markers versus metformin alone (PMID 39867806; PMID 38264892). Small, single-center, non-blinded: early evidence, not proof, and it was never tested as a replacement for medication.

Does it actually expel intestinal worms?

That is its signature traditional use in Ayurveda (krimi), and the species name anthelminticum reflects it, but no published human trial has tested it for worm infections (Easy Ayurveda). A 2024 laboratory study explored anti-filarial mechanisms (PMID 39139251), which is not the same as a proven treatment. Test tubes again, not patients.

What dose of aranya jeeraka was studied?

Only one research regimen exists: 500 mg of seed powder in capsule form, once daily for 12 weeks, studied as an add-on to metformin 500 mg in type-2 diabetes patients (PMID 39867806). No pharmacopoeial dose was identified, and the trial dose is not a personal recommendation.

Is aranya jeeraka safe in pregnancy?

There are no human safety data for pregnancy, breastfeeding, or children, so avoid use in these groups without clinical guidance. The two small trials lasted only 12 weeks and were not designed as safety studies (PMID 39867806). Safety data is limited: talk to a clinician.

Can I take aranya jeeraka instead of metformin?

No. Both human trials tested the seed powder only as an add-on to metformin, never as a substitute (PMID 39867806; PMID 38264892). Do not stop or change prescribed diabetes medication; discuss any supplement with your clinician first. I am not softening this one.

Sources

The Ayurvedic background, Raja Nighantu classification, indications, and the mislabeling warning draw on the Easy Ayurveda monograph for Centratherum anthelminticum (Easy Ayurveda). Botanical identity, morphology, and properties come from the Satya Sai Murlidhar Ayurvedic College monograph on Aranyajiraka (SSM monograph PDF). The first diabetes trial is Mudassir HA et al.'s 2025 non-blind randomized controlled trial of C. anthelminticum seeds on glycated hemoglobin, cardiovascular disease risks, and dyslipidemia in type-2 diabetic patients in Karachi (Pak J Med Sci 41(1):257–262, DOI: 10.12669/pjms.41.1.8496; n=40 patients plus 20 healthy volunteers, 500 mg seed powder plus metformin versus metformin, 12 weeks; PMID 39867806). The second is the 2023 randomized non-blinded 3-month trial of the seed powder's effect on risk-factor markers in metformin-treated type-2 diabetic patients (Pak J Pharm Sci; n=60, 500 mg/day add-on; PMID 38264892). The anti-filarial laboratory study is the 2024 biochemical and HRAMS proteomics investigation of C. anthelminticum (RSC Adv.; laboratory/mechanistic only; PMID 39139251). The nanoparticle study is the 2024 green synthesis of silver nanoparticles using C. anthelminticum extract against breast cancer cells (Asian Pac J Cancer Prev.; in-vitro materials research, not treatment evidence; PMID 39205569).

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.